Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses.
about
Biomaterial Applications in Cell-Based Therapy in Experimental StrokeComplement activation in the context of stem cells and tissue repairThe immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS)Mesenchymal Stem Cell Therapy for Cutaneous WoundsCell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cellsChronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALSTargeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical EvidenceThe ischemic environment drives microglia and macrophage functionDeveloping Cellular Therapies for StrokeConditioned medium of human adipose-derived mesenchymal stem cells mediates protection in neurons following glutamate excitotoxicity by regulating energy metabolism and GAP-43 expressionIntravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury.Administration of TSG-6 improves memory after traumatic brain injury in mice.Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer's disease model.Effects of bone marrow stromal cell transplantation through CSF on the subacute and chronic spinal cord injury in rats.Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease.A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis.Neural progenitor cells attenuate inflammatory reactivity and neuronal loss in an animal model of inflamed AD brainMesenchymal stromal cells integrate and form longitudinally-aligned layers when delivered to injured spinal cord via a novel fibrin scaffold.Current status of cell therapies in stroke.Optimizing the success of cell transplantation therapy for stroke.BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury.Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms.Effects of combinatorial treatment with pituitary adenylate cyclase activating peptide and human mesenchymal stem cells on spinal cord tissue repair.Induction of neuro-protective/regenerative genes in stem cells infiltrating post-ischemic brain tissue.Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responsesBone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain traumaCharacterization of dental pulp stem/stromal cells of Huntington monkey tooth germs.Intraperitoneal infusion of mesenchymal stem/stromal cells prevents experimental autoimmune uveitis in miceGp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury.Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells.Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory propertiesHematopoietic stem cell transplantation protects mice from lethal stroke.Toll-like receptor 3 and suppressor of cytokine signaling proteins regulate CXCR4 and CXCR7 expression in bone marrow-derived human multipotent stromal cells.PACAP38 differentially effects genes and CRMP2 protein expression in ischemic core and penumbra regions of permanent middle cerebral artery occlusion model mice brain.Distribution of mesenchymal stem cells and effects on neuronal survival and axon regeneration after optic nerve crush and cell therapy.Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis.Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.
P2860
Q26747619-BB46BF0F-C0DF-4278-88F6-F22A2EA268BAQ26782203-0D483350-A5A7-480B-9C7D-E49BE291B9EDQ26823691-F18BC9F1-1B3F-4F88-B275-745A4B9B1269Q26860887-164792BD-C050-4744-B454-F2B6972F9339Q27026350-9DC690AB-64F8-40A9-BD24-BFD79699E7C6Q27303112-D8C56249-4D4A-4B72-ABE2-96BF669E7898Q27340206-E55156B9-8EE4-478F-98FA-7BFF4782AE34Q28079089-79E7511E-9B30-42F6-BD48-62FE60465305Q28086874-C7C24AEC-8E38-4B31-B635-49F2756F463AQ28087451-8C5C8268-A194-43DB-8544-7A9D6EA2B979Q28396387-8E6FB64D-5491-4FC0-B625-91A45A075C38Q29620590-7C5506A4-62A6-4C30-8B0C-034678F00959Q30533831-862D5F97-B15A-4AA0-9580-23CCB901FE92Q30548200-400B2D0E-1388-4F09-B953-730CB533ED88Q30846817-A13E581A-9875-41F8-8684-6B326E55804EQ31139130-0AB06B7B-7F8D-45CA-A9A4-1CF0C1087B77Q33533774-57E8BD36-7A0A-4CC7-A537-039CCEF0A4D6Q33570359-54AC2FD6-0D97-45B8-A1D7-0D97ADF8DC7DQ33577019-94EDC76B-9505-4840-BE49-18ABBB03C1DAQ33582786-6E420753-1B22-4F3F-BA23-03E170E3D838Q33587508-B2C2E9F1-378A-4F05-9850-DEAA93D521BAQ33614825-1892240A-3C6F-4A10-9E18-12AF43FC9BB7Q33636930-5E41341E-99C3-4194-B772-37960C0A7051Q33672421-20FD5A30-618E-437D-9C6F-31A110BAF6E7Q33713663-D67708BC-E200-459E-8FD5-59D069A6DD46Q33781107-0F67D9AC-7D31-418C-903D-E1B17936C46EQ33945052-4D9BA220-2252-4C8A-A929-873B2E2949ADQ33958064-45CA73DA-2378-4DF6-9774-E2E493CCACA8Q34000812-12F8D393-8D33-45D7-A644-EF2A2B8B1757Q34017095-4A27591E-37DE-4C95-AB56-7BAC20638F65Q34022340-11AE69C9-EC8F-4D56-AB3C-6290E8B83015Q34049608-32A86386-4AE0-4567-A349-F714078B01C9Q34062490-0DF130B8-5594-4178-8592-1779C683A43EQ34068369-5B74124D-401C-46D6-BC76-E2821478AB46Q34236913-E4A4B840-B318-466F-9256-7AB47409927FQ34321571-DAB0F207-74CE-4106-A522-A2A20E8EFF86Q34358768-A1013252-0036-4D9C-A8F0-386C584979FEQ34408378-D9158D69-1E85-4039-9A56-2BB4BA143073Q34429538-890A64CD-B4DB-4ED0-9B28-C31C4BDCDD04Q34432396-5BA3890B-28E6-44E7-887F-B8662E29B421
P2860
Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Stem/progenitor cells from bon ...... inflammatory/immune responses.
@en
type
label
Stem/progenitor cells from bon ...... inflammatory/immune responses.
@en
prefLabel
Stem/progenitor cells from bon ...... inflammatory/immune responses.
@en
P2093
P2860
P356
P1476
Stem/progenitor cells from bon ...... inflammatory/immune responses.
@en
P2093
Andrew P Robinson
Hirokazu Ohtaki
Jessica E Foraker
Joni H Ylostalo
Roxanne L Reger
Seiji Shioda
P2860
P304
14638-14643
P356
10.1073/PNAS.0803670105
P407
P577
2008-09-15T00:00:00Z